Not applicableStudy completedNCT02620189What this trial is testingTh17 Responses Evaluated in RA Patients on Inhibitors of TNFαWho this might be right forRheumatoid Arthritis Queen Mary University of London 60
Large-scale testing (Phase 3)Study completedNCT00996606What this trial is testingTocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDsWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00595413What this trial is testingAtacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)Who this might be right forRheumatoid Arthritis EMD Serono 311
Large-scale testing (Phase 3)Study completedNCT02720523What this trial is testingCompare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDsWho this might be right forRheumatoid Arthritis AbbVie 197
Testing effectiveness (Phase 2)Looking for participantsNCT06701903What this trial is testingStudy of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderWho this might be right forGeneralized Anxiety Disorder Intra-Cellular Therapies, Inc. 570
Large-scale testing (Phase 3)Ended earlyNCT00476996What this trial is testingOcrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)Who this might be right forRheumatoid Arthritis Genentech, Inc. 836
Large-scale testing (Phase 3)UnknownNCT02916641What this trial is testingFuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic AcidWho this might be right forPrimary Biliary Cirrhosis Xijing Hospital of Digestive Diseases 200
Testing effectiveness (Phase 2)Ended earlyNCT03410056What this trial is testingSafety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis RA Amgen 36
Post-approval studies (Phase 4)Study completedNCT01399697What this trial is testingRoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 261
Large-scale testing (Phase 3)Ended earlyNCT01209689What this trial is testingTocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist TherapyWho this might be right forSpondylitis, Ankylosing Hoffmann-La Roche 113
Testing effectiveness (Phase 2)Study completedNCT00810836What this trial is testingEfficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Biogen 153
Testing effectiveness (Phase 2)Study completedNCT03233230What this trial is testingPhase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis EMD Serono Research & Development Institute, Inc. 390
Large-scale testing (Phase 3)Looking for participantsNCT06332534What this trial is testingCrohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 110
Large-scale testing (Phase 3)Study completedNCT00578305What this trial is testingRituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 185
Testing effectiveness (Phase 2)Study completedNCT01373151What this trial is testingPhase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to MethotrexateWho this might be right forRheumatoid Arthritis CSL Behring 418
Testing effectiveness (Phase 2)Ended earlyNCT00458861What this trial is testingBG9924 in Combination With Methotrexate for Participants With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Biogen 115
Post-approval studies (Phase 4)Study completedNCT01717222What this trial is testingEffect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic CholecystectomyWho this might be right forPain, PostoperativeAnalgesic RequirementStress Response+2 more Jawaharlal Institute of Postgraduate Medical Education & Research 50
Testing effectiveness (Phase 2)Ended earlyNCT04594694What this trial is testingStudy of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBCWho this might be right forPrimary Biliary Cholangitis Intercept Pharmaceuticals 75
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159What this trial is testingA Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis AbbVie 1,629
Large-scale testing (Phase 3)Study completedNCT01835470What this trial is testingEfficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in JapanWho this might be right forJuvenile Idiopathic Arthritis Bristol-Myers Squibb 23